218 related articles for article (PubMed ID: 34239271)
1. Fasudil prevents liver fibrosis
Han QJ; Mu YL; Zhao HJ; Zhao RR; Guo QJ; Su YH; Zhang J
World J Gastroenterol; 2021 Jun; 27(24):3581-3594. PubMed ID: 34239271
[TBL] [Abstract][Full Text] [Related]
2. Exosomes derived from natural killer cells inhibit hepatic stellate cell activation and liver fibrosis.
Wang L; Wang Y; Quan J
Hum Cell; 2020 Jul; 33(3):582-589. PubMed ID: 32449114
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Rho-Kinase Downregulates Th17 Cells and Ameliorates Hepatic Fibrosis by
Zhou W; Yang Y; Mei C; Dong P; Mu S; Wu H; Zhou Y; Zheng Y; Guo F; Yang JQ
Cells; 2019 Oct; 8(10):. PubMed ID: 31623153
[TBL] [Abstract][Full Text] [Related]
4. AMP-activated protein kinase activator, HL156A reduces thioacetamide-induced liver fibrosis in mice and inhibits the activation of cultured hepatic stellate cells and macrophages.
Lee HS; Shin HS; Choi J; Bae SJ; Wee HJ; Son T; Seo JH; Park JH; Kim SW; Kim KW
Int J Oncol; 2016 Oct; 49(4):1407-14. PubMed ID: 27498767
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor binding protein related protein 1 knockdown attenuates hepatic fibrosis via the regulation of MMPs/TIMPs in mice.
Ren JJ; Huang TJ; Zhang QQ; Zhang HY; Guo XH; Fan HQ; Li RK; Liu LX
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):38-47. PubMed ID: 30243878
[TBL] [Abstract][Full Text] [Related]
6. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potentials of fasudil in liver fibrosis.
Xi Y; Xu PF
World J Gastroenterol; 2021 Dec; 27(45):7859-7861. PubMed ID: 34963748
[TBL] [Abstract][Full Text] [Related]
8. N-n-Butyl haloperidol iodide ameliorates liver fibrosis and hepatic stellate cell activation in mice.
Shen DF; Cheng H; Cai BZ; Cai WF; Wang B; Zhu Q; Wu YB; Liu M; Chen RJ; Gao FF; Zhang YM; Niu YD; Shi GG
Acta Pharmacol Sin; 2022 Jan; 43(1):133-145. PubMed ID: 33758354
[TBL] [Abstract][Full Text] [Related]
9. Fasudil alleviates hepatic fibrosis in type 1 diabetic rats: involvement of the inflammation and RhoA/ROCK pathway.
Xie Y; Song T; Huo M; Zhang Y; Zhang YY; Ma ZH; Wang N; Zhang JP; Chu L
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5665-5677. PubMed ID: 30229844
[TBL] [Abstract][Full Text] [Related]
10. Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells.
Chen L; Li L; Chen J; Li L; Zheng Z; Ren J; Qiu Y
Oncotarget; 2015 Dec; 6(40):42530-40. PubMed ID: 26729705
[TBL] [Abstract][Full Text] [Related]
11. Adenoviral delivery of dominant-negative transforming growth factor beta type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats.
Marquez-Aguirre A; Sandoval-Rodriguez A; Gonzalez-Cuevas J; Bueno-Topete M; Navarro-Partida J; Arellano-Olivera I; Lucano-Landeros S; Armendariz-Borunda J
J Gene Med; 2009 Mar; 11(3):207-19. PubMed ID: 19189315
[TBL] [Abstract][Full Text] [Related]
12. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, ameliorates hepatic fibrosis in rats with type 2 diabetes.
Zhou H; Fang C; Zhang L; Deng Y; Wang M; Meng F
Chin Med J (Engl); 2014; 127(2):225-31. PubMed ID: 24438608
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
[TBL] [Abstract][Full Text] [Related]
14. Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro.
Tao YY; Wang QL; Shen L; Fu WW; Liu CH
Exp Biol Med (Maywood); 2013 Nov; 238(11):1284-96. PubMed ID: 24006304
[TBL] [Abstract][Full Text] [Related]
15. Valproate ameliorates thioacetamide-induced fibrosis by hepatic stellate cell inactivation.
Aher JS; Khan S; Jain S; Tikoo K; Jena G
Hum Exp Toxicol; 2015 Jan; 34(1):44-55. PubMed ID: 24812151
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats.
Abramovitch S; Dahan-Bachar L; Sharvit E; Weisman Y; Ben Tov A; Brazowski E; Reif S
Gut; 2011 Dec; 60(12):1728-37. PubMed ID: 21816960
[TBL] [Abstract][Full Text] [Related]
17. Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice.
Li YL; Wu J; Wei D; Zhang DW; Feng H; Chen ZN; Bian H
Liver Int; 2009 Apr; 29(4):593-602. PubMed ID: 19192169
[TBL] [Abstract][Full Text] [Related]
18. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
[TBL] [Abstract][Full Text] [Related]
19. Cultured Mycelium Cordyceps sinensis allevi¬ates CCl4-induced liver inflammation and fibrosis in mice by activating hepatic natural killer cells.
Peng Y; Huang K; Shen L; Tao YY; Liu CH
Acta Pharmacol Sin; 2016 Feb; 37(2):204-16. PubMed ID: 26592510
[TBL] [Abstract][Full Text] [Related]
20. Treatment with 4-methylpyrazole modulated stellate cells and natural killer cells and ameliorated liver fibrosis in mice.
Yi HS; Eun HS; Lee YS; Jung JY; Park SH; Park KG; Choi HS; Suh JM; Jeong WI
PLoS One; 2015; 10(5):e0127946. PubMed ID: 26024318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
